enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
2.050
+0.090 (4.59%)
At close: Sep 22, 2026, 4:00 PM EDT
2.040
-0.010 (-0.49%)
After-hours: Sep 22, 2026, 7:40 PM EDT
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $137.38 million as of September 22, 2026. Its market cap has decreased by -60.65% in one year.
Market Cap
137.38M
Enterprise Value
-95.67M
1-Year Change
-60.65%
Ranking
Category
Stock Price
$2.05
ChartMarket Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $137.38M, a decrease of -11.88%. That is a compound annual growth rate of -2.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 137.38M | -77.29% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 133.83M |
| Unicycive Therapeutics | 133.71M |
| Biomea Fusion | 132.65M |
| Milestone Pharmaceuticals | 129.05M |
| Inovio Pharmaceuticals | 128.21M |
| LENZ Therapeutics | 127.88M |
| ProMIS Neurosciences | 125.64M |
| Cibus | 123.05M |